People with diabetes often have to check their blood sugar using a drop of blood squeezed from a finger, thigh or some other part of the body.
It's an unpleasant part of managing the disease, but when diabetes patients insulin levels falter, their sugar levels don't just rise in the bloodstream. They rise in urine and tears, too. Now, one researcher is working on creating contact lenses that are able to detect unusual blood sugar levels in the eyes, then change color in response.
Chemist Jun Hu at the University of Akron in Ohio is working on a contact lens coated with a chemical that reacts to glucose in the tears that naturally surround the eye. That chemical reaction makes the lens change color.
A Salk Institute Study published in the journal Cell Metabolism, shows that if you condense the total time you eat each day to only eight hours -- say 8:00 a.m. to 4:00 p.m. -- you can prevent weight gain and reduce diabetes risk, without changing your total calorie consumption.
Again: if you eat exactly the calories you're currently eating, but squish the total time you eat into eight hours a day, you'll avoid packing on pounds and lower your risk of all sorts of metabolic badness including diabetes.
Patrick Tso, PhD, professor in the UC Department of Pathology and Laboratory Medicine, has published research on the ability of apoA-IV to reduce blood sugar levels and enhance insulin secretion.
The results appear the week of May 21, 2012, in the online early edition of Proceedings of the National Academy of Sciences.
ApoA-IV is secreted by the small intestine in response to fat absorption. Previous studies have shown apoA-IV to be elevated in humans following gastric bypass -- coinciding with improvement in symptoms for diabetes.
New research shows that people with diabetes are living longer, and this is likely due to heart-healthy habits and tighter control of blood sugar levels.
Many people may only associate diabetes with vision loss, kidney disease, and limb amputations, but it also increases the risk for heart disease and stroke. From 1996 to 2006, however, the risk of dying from heart disease and stroke decreased by 40% among people with diabetes.
People with diabetes do die earlier than people without diabetes, but this gap appears to be getting smaller.
Great News! Have to admit to over eating a bit on a recent 8 day Southern Caribbean cruise earlier this year- Charles
Diabetes Daily Post has signed with Royal Caribbean Cruise Line to conduct an educational and motivational diabetes cruise which sails on January 7, 2013 for a 6 day Caribbean cruise.
Along with Jorge Prada, MD, an Educator and Diabetes Researcher, Susan Sloane Pharmacist and Certified Diabetes Educator, a member of American Diabetes Association board of director and Charles Liu, Clinical Pharmacist with special interest in Type 2 Diabetes.
The program is tailored to both Type 1 and Type 2 Diabetes Patients for a better management, awareness and course-changing experiences. The participants will receive a broad and comprehensive education including a diabetes-exercise session and on board two-mile fun walk for diabetes to raise funds for the American Diabetes Association.
The Diabetes Daily Post www.diabetesdailypost.com based in Novi, Michigan was created in 2011 to educate, enrich, and expand the knowledge of Diabetes. Its goal is to keep you informed about the latest news and drug innovations, provide health tools for diabetes management, motivate with triumph personal stories and talk about key opinion leaders who have worked on the elusive cure for Diabetes. The Diabetes Daily Post offers its “Living Well” Diabetes Education program both on cruises and in major cities.
Recent studies might suggest an increase of Type 2 diabetes among children and young adults, but the real low hanging fruit, according to diabetes and policy experts, may be among the Medicare population.
Those 65 and older tend to be a costly population for health care services, according to Matthew Mawby, the government affairs officer for drugmaker Novo Nordisk. Intervention and prevention programs for pre-diabetics could be a more effective means of care, Mawby said during a policy panel on Tuesday.
A new report in Population Health Management (PHM) discusses the Diabetes 2025 Model for the U.S., its predictions on the increase in the number of people who have diabetes, and how this rise could impact the health care system.
The researchers explained their predictions for specific states and population subgroups with 15-year projections. Based on the Diabetes 2025 Model, the authors believe that diabetes (mainly type 2) will affect 53.1 million Americans by 2025; it’s an increase of 64 percent from 2010.
The World Diabetes Day 2012 campaign marks the fourth year of the five-year theme on “Diabetes education and prevention.”
The United Nations Summit on Non-Communicable Diseases (NCDs) in September 2011 increased the urgency to take action on diabetes. We need to widen awareness of the factors responsible for the global diabetes and NCD epidemic and the solutions that are required to counter it.
This year’s campaign links the urgent need for action to the protection of the health of our future generations. Focus will be placed on highlighting the importance of education - for health professionals, people with diabetes and people at risk – in reducing the impact of diabetes throughout the world.
Children and young people will be the driving force for the promotion and dissemination of education and prevention messages. We hope these will inspire and engage local communities to recognise the importance of early awareness of the risks and dangers of diabetes.
The slogan of the campaign is: Diabetes: protect our future
Our three key messages are:
Access to essential education for everyone
The way we live is putting our health at risk
People with diabetes face stigma and discrimination
A selection of posters has been developed to promote the campaign messages and a special animated video is in development.
Lawyers for a French pharmaceutical group suspected in the deaths of at least 500 people argued Monday that a trial against their client should be halted as two separate cases should be rolled into one before the court can proceed.
The trial of Servier on charges of "aggravated deception" opened in Nanterre, west of Paris just as a similar case is being investigated in the French capital over the diabetes drug Mediator.
The company is accused of hiding that Mediator - also used for weight loss - contained an amphetamine called benfluorex, which was taken off the market in 2009 after being found to thicken heart valves.